Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection.


PURPOSE To evaluate the clinical efficacy of FK-506 on suppressing high-risk cornea transplantation rejection. METHODS In a randomized controlled clinical trial, 56 eyes of 56 patients with high-risk keratoplasty (including total corneal transplantation TCT, total corneal transplantation with circular lamellar sclera CST, vascularization corneal… (More)


  • Presentations referencing similar topics